Myriad Genetics buy Raymond James
Start price
25.02.25
/
50%
€11.40
Target price
25.02.26
€18.10
Performance (%)
-66.14%
Price
08:46
?
This prediction will end soon
Summary
This prediction is currently active. Massive losses of -66.14% have been the result for the BUY prediction by Raymond_James. This prediction currently runs until 25.02.26. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Myriad Genetics | -12.617% | -12.617% |
| iShares Core DAX® | 0,46 % | -1,53 % |
| iShares Nasdaq 100 | -1,79 % | -5,38 % |
| iShares Nikkei 225® | 5,12 % | 8,05 % |
| iShares S&P 500 | -1,76 % | -3,82 % |
Comments by Raymond_James for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $19.00 price target on the stock, down previously from $27.00.
Ratings data for MYGN provided by MarketBeat